Finance

Lists
Why is 539997 down 2,01%?
Dive Deeper
539997:BOM
Kwality Pharmaceuticals Ltd
₹3 324,00
-2,01%
(-68,10) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539997...
Open
₹3 379,65
High
₹3 474,95
Low
₹3 227,00
Mkt. cap
34,31 mjd
Avg. vol.
5,88 k
Volume
4,00 k
P/E ratio
42,55
52-wk high
₹3 848,00
52-wk low
₹828,80
EPS
₹78,11
Shares outstanding
10,38 m
No. of employees
1 k
Open
₹3 379,65
High
₹3 474,95
Low
₹3 227,00
Mkt. cap
34,31 mjd
Avg. vol.
5,88 k
Volume
4,00 k
P/E ratio
42,55
52-wk high
₹3 848,00
52-wk low
₹828,80
EPS
₹78,11
Shares outstanding
10,38 m
No. of employees
1 k
News stories
From web sources and news partners
About Kwality Pharmaceuticals Ltd
CEO-
Employees1,14 k
Founded1983
Headquarters-
SectorPharmaceutical industry
Websitekwalitypharma.com
Last report
10 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,62 mjd / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,11 mjd
1,23 mjd
1,57 mjd
1,62 mjd
Cost of goods sold
546,25 m
590,97 m
942,31 m
874,25 m
Cost of revenue
546,25 m
590,97 m
942,31 m
874,25 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
133,13 m
143,58 m
174,62 m
147,44 m
Operating expense
351,33 m
386,86 m
291,65 m
382,79 m
Total operating expenses
897,58 m
977,83 m
1,23 mjd
1,26 mjd
Operating income
212,93 m
256,56 m
337,17 m
366,48 m
Other non operating income
-1,00 k
-1,00 k
2,00 k
-1,00 k
EBT including unusual items
184,50 m
223,45 m
316,68 m
339,87 m
EBT excluding unusual items
184,50 m
231,75 m
309,56 m
339,87 m
Income tax expense
43,35 m
63,45 m
63,58 m
83,65 m
Effective tax rate
23,49%
28,40%
20,08%
24,61%
Other operating expenses
168,61 m
195,06 m
64,39 m
185,41 m
Net income
141,16 m
160,09 m
253,01 m
256,24 m
Net profit margin
12,71%
12,97%
16,10%
15,78%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,25 m
-
Interest expense
-28,42 m
-24,82 m
-28,87 m
-26,61 m
Net interest expenses
-28,42 m
-24,82 m
-27,61 m
-26,61 m
Depreciation and amortization charges
49,60 m
48,22 m
52,64 m
49,95 m
EBITDA
261,55 m
302,29 m
386,70 m
416,00 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme